Skip to main content
Clinical Trials/NCT02543580
NCT02543580
Completed
N/A

Transcutaneous Electrical Acupoint Stimulation Decreases Remifentanil Consumption and Postoperative Pain in Patients Undergoing Radical Mastectomy: Dual Acupoints Versus Single Acupoint in a Prospective Randomized Controlled Trial

Xijing Hospital1 site in 1 country153 target enrollmentJuly 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postoperative
Sponsor
Xijing Hospital
Enrollment
153
Locations
1
Primary Endpoint
dose of remifentanil during anesthesia
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effects of transcutaneous electric acupoint stimulation(TEAS) at single acupoint or dual acupoints on opioid consumption and postoperative pain in patients undergoing radical mastectomy

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
June 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xijing Hospital
Responsible Party
Principal Investigator
Principal Investigator

wangqiang

Professor

Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • patients aged from 18 to 65 yrs
  • body mass index (BMI) of 18 to 30 kg/m2
  • elective radical mastectomy under general anesthesia

Exclusion Criteria

  • contradictions to electric stimulation
  • difficulties in communication
  • histories of general anesthesia, drug or alcohol abuse or addiction
  • cardiac dysfunction or severe hypertension, confirmed hepatic dysfunction and renal impairment
  • participants recruited into other clinical trials during last three months

Outcomes

Primary Outcomes

dose of remifentanil during anesthesia

Time Frame: from start of anesthesia to extubation, on average 2 hours

Secondary Outcomes

  • incidence of respiratory depression during recovery(from extubation to discharge from post anesthesia care unit, approximately 40 minutes on average)
  • visual analogue scale during recovery(from arriving to discharge from post anesthesia care unit, approximately 30 minutes on average)
  • pain score at 6 months after surgery(from discharge from hospital to 6 months after surgery, approximately 3 months)
  • time to extubation(from end of remifentanil infusion to extubation,approximately 10 minutes on average)
  • incidence of nausea and vomiting during recovery(from extubation to discharge from post anesthesia care unit, approximately 40 minutes on average)
  • time to recall(from end of remifentanil infusion to patient response to verbal command,approximately 10 minutes on average)
  • visual analogue scale at 24 hour after surgery(from end of surgery to 24 hours after surgery, totally 24 hours)
  • pain score at 3 months after surgery(from discharge from hospital to 3 months after surgery, approximately 3 months)

Study Sites (1)

Loading locations...

Similar Trials